All Chapters 1-58 | Pharmacology A Patient Centered Nursing Process Approach|Test Bank 11th Edition by Linda E. McCuistion

TEST BANK Test Bank for Pharmacology A Patient Centered Nursing Process Approach, 11th Edition by Linda E. McCuistion | All Chapters 1-58 TEST BANK Test Bank forPharmacology A Patient Centered Nursing Process Approach, 11th Edition Table of Contents Chapter 01: The Nursing Process and Patient-Centered Care............................................................................................ 4 Chapter 02: Drug Development and Ethical Considerations.............................................................................................. 9 Chapter 03: Pharmacokinetics and Pharmacodynamics................................................................................................... 16 Chapter 04: Pharmacogenetics........................................................................................................................................ 28 Chapter 05: Complementary and Alternative Therapies.................................................................................................. 31 Chapter 06: Pediatric Considerations............................................................................................................................... 36 Chapter 07: Geriatric Considerations............................................................................................................................... 43 Chapter 08: Drugs in Substance Use Disorder................................................................................................................. 48 Chapter 09: Safety and Quality........................................................................................................................................ 54 Chapter 10: Drug Administration .................................................................................................................................... 60 Chapter 11: Drug Calculations ........................................................................................................................................ 65 Chapter 12: Fluid Volume and Electrolytes..................................................................................................................... 70 Chapter 13: Vitamin and Mineral Replacement............................................................................................................... 79 Chapter 14: Nutritional Support ...................................................................................................................................... 86 Chapter 15: Adrenergic Agonists and Antagonists.......................................................................................................... 93 Chapter 16: Cholinergic Agonists and Antagonists......................................................................................................... 98 Chapter 17: Stimulants.................................................................................................................................................. 104 Chapter 18: Depressants................................................................................................................................................ 108 Chapter 19: Antiseizure Drugs....................................................................................................................................... 114 Chapter 20: Drugs for Parkinsonism and Alzheimer Disease ........................................................................................ 121 Chapter 21: Drugs for Neuromuscular Disorders and Muscle Spasms.......................................................................... 127 Chapter 22: Antipsychotics and Anxiolytics.................................................................................................................. 132 Chapter 23: Antidepressants and Mood Stabilizers ....................................................................................................... 139 Chapter 24: Antiinflammatories.................................................................................................................................... 146 Chapter 25: Analgesics.................................................................................................................................................. 153 Chapter 26: Penicillins, Other Beta-Lactams, and Cephalosporins................................................................................ 159 Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, and Lipopeptides........................ 164 Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, and Fluoroquinolones................................................. 168 Chapter 29: Sulfonamides and Nitroimidazoles Antibiotics.......................................................................................... 172 Chapter 30: Antituberculars, Antifungals, and Antivirals.............................................................................................. 176 Chapter 31: Antimalarials, Anthelmintics, and Peptides................................................................................................ 184 Chapter 32: HIV- and AIDS-Related Drugs.................................................................................................................. 187 Chapter 33: Transplant Drugs........................................................................................................................................ 191 Chapter 34: Vaccines..................................................................................................................................................... 194 Chapter 35: Anticancer Drugs ....................................................................................................................................... 198 Chapter 36: Targeted Therapies to Treat Cancer........................................................................................................... 203 Chapter 37: Biologic Response Modifiers..................................................................................................................... 208 Chapter 38: Upper Respiratory Disorders...................................................................................................................... 213 Chapter 39: Lower Respiratory Disorders..................................................................................................................... 219 Chapter 40: Cardiac Glycosides, Antianginals, and Antidysrhythmics.......................................................................... 226 Test Bank forPharmacology A Patient Centered Nursing Process Approach, 11th Edition Chapter 41: Diuretics..................................................................................................................................................... 236 Chapter 42: Antihypertensives...................................................................................................................................... 242 Chapter 43: Anticoagulants, Antiplatelets, and Thrombolytics...................................................................................... 251 Chapter 44: Antihyperlipidemics and Drugs to Improve Peripheral Blood Flow......................................................... 260 Chapter 45: Gastrointestinal Tract Disorders................................................................................................................. 267 Chapter 46: Antiulcer Drugs.......................................................................................................................................... 276 Chapter 47: Eye and Ear Disorders................................................................................................................................ 284 Chapter 48: Dermatologic Disorders............................................................................................................................. 289 Chapter 49: Pituitary, Thyroid, Parathyroid, and Adrenal Disorders............................................................................. 295 Chapter 50: Antidiabetics.............................................................................................................................................. 304 Chapter 51: Urinary Disorders....................................................................................................................................... 312 Chapter 52: Pregnancy and Preterm Labor .................................................................................................................... 318 Chapter 53: Labor, Delivery, and Postpartum................................................................................................................ 326 Chapter 54: Neonatal and Newborn............................................................................................................................... 332 Chapter 55: Women’s Reproductive Health .................................................................................................................. 335 Chapter 56: Men’s Health and Reproductive Disorders............................................................................................... 344 Chapter 57: Sexually Transmitted Infections................................................................................................................. 350 Chapter 58: Adult and Pediatric Emergency Drugs....................................................................................................... 354 Test Bank forPharmacology A Patient Centered Nursing Process Approach, 11th Edition Chapter 01: The Nursing Process and Patient-Centered Care McCuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition MULTIPLE CHOICE 1. All of the following would be considered subjective data, EXCEPT: a. Patient-reported health history b. Patient-reported signs and symptoms of their illness c. Financial barriers reported by the patient’s caregiver d. Vital signs obtained from the medical record ANS: D Subjective data is based on what patients or family members communicate to the nurse. Patient- reported health history, signs and symptoms, and caregiver reported financial barriers would be considered subjective data. Vital signs obtained from the medical record would be considered objective data. DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning MSC: NCLEX: Management of Client Care 2. The nurse is using data collected to define a set of interventions to achieve the